New hope for lung cancer patients: drug study aims to keep cancer at bay
NCT ID NCT07161388
Summary
This study is observing how well a drug called durvalumab works to help control limited stage small-cell lung cancer after patients finish standard chemoradiation treatment. It will follow 200 patients in China who have not gotten worse after their initial treatment. The goal is to see if adding durvalumab helps keep the cancer from progressing longer and is safe in real-world hospital settings.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIMITED-STAGE SMALL-CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
NOT_YET_RECRUITINGBeijing, China
-
Research Site
RECRUITINGBeijing, China
-
Research Site
NOT_YET_RECRUITINGCangzhou, China
-
Research Site
RECRUITINGDongguan, China
-
Research Site
RECRUITINGFuzhou, China
-
Research Site
NOT_YET_RECRUITINGGuangzhou, China
-
Research Site
RECRUITINGGuangzhou, China
-
Research Site
RECRUITINGHuzhou, China
-
Research Site
RECRUITINGJinan, 250117, China
-
Research Site
RECRUITINGJinan, China
-
Research Site
NOT_YET_RECRUITINGJinzhou, China
-
Research Site
NOT_YET_RECRUITINGNanjing, China
-
Research Site
RECRUITINGNanning, China
-
Research Site
RECRUITINGNingbo, China
-
Research Site
NOT_YET_RECRUITINGShanghai, China
-
Research Site
NOT_YET_RECRUITINGShenyang, China
-
Research Site
NOT_YET_RECRUITINGShenzhen, China
-
Research Site
RECRUITINGShijiazhuang, China
-
Research Site
RECRUITINGTaiyuan, China
-
Research Site
RECRUITINGTianjing, China
-
Research Site
NOT_YET_RECRUITINGWuhan, China
-
Research Site
RECRUITINGWuhan, China
-
Research Site
NOT_YET_RECRUITINGWuxi, China
-
Research Site
RECRUITINGYangzhou, China
-
Research Site
NOT_YET_RECRUITINGZhengzhou, China
-
Research Site
RECRUITINGZhengzhou, China
Conditions
Explore the condition pages connected to this study.